Erasca Announces Proposed Public Offering of $500 Million of Common Stock
SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for…
Read the full articleYou might also wanna read
Erasca (ERAS) Plans $500 Million Public Offering to Fund Development
Related Stocks: ERAS
GuruFocus·3d ago
ERAS Developments: Joint Managers for Offering Announced
Related Stocks: ERAS
GuruFocus·3d ago
OpenAI Reportedly Prepares for IPO With Goldman Sachs and Morgan Stanley
OpenAI is reportedly preparing for one of the most closely watched initial public offerings in technology history, with Goldman Sachs and Mo
insightarea.com·1mo ago
Share Offering for New Cooperative Banking Initiative Begins on July 22
CySEC has approved a public offering of up to 42 million new shares
POLITIS EN·6d ago
Attovia Therapeutics files for Nasdaq IPO to fund immune-disease biologics
Tao Fu's San Carlos biotech is seeking an ATTO listing before disclosing price range, share count or valuation.
runtimewire.com·2d ago
Biotech NRx to sell new shares to fund growth and operations
#NRXP NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
stocktitan.net·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.